* Pfizer and Astellas announce top-line results from phase 4 PLATO trial of XTANDI capsules in patients with metastatic castration-resistant prostate cancer Source text for Eikon: Further company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback